Board Meeting Details
- Meeting Date: Wednesday, July 29, 2026
- Primary Agenda: To consider and approve the unaudited financial results of the company for the quarter ended June 30, 2026 (Q1 FY2027)
- The agenda may include other items (inter-alia)
Trading Window Closure
- Trading window for company securities remains closed until July 31, 2026
- This is in continuation of the company's previous letter dated June 26, 2026 regarding trading window closure
Financial Impact
Financial impact not quantified in the disclosure. The meeting will consider and approve the quarterly financial results.
#Tags: #JagsonpalPharmaceuticals #SEBIRegulation29 #BoardMeeting #QuarterlyResults #TradingWindowClosure #Neutral